Correlation Between Hillstream Biopharma and Acrivon Therapeutics,
Can any of the company-specific risk be diversified away by investing in both Hillstream Biopharma and Acrivon Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Hillstream Biopharma and Acrivon Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Hillstream Biopharma and Acrivon Therapeutics, Common, you can compare the effects of market volatilities on Hillstream Biopharma and Acrivon Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Hillstream Biopharma with a short position of Acrivon Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Hillstream Biopharma and Acrivon Therapeutics,.
Diversification Opportunities for Hillstream Biopharma and Acrivon Therapeutics,
0.47 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Hillstream and Acrivon is 0.47. Overlapping area represents the amount of risk that can be diversified away by holding Hillstream Biopharma and Acrivon Therapeutics, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Acrivon Therapeutics, and Hillstream Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Hillstream Biopharma are associated (or correlated) with Acrivon Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Acrivon Therapeutics, has no effect on the direction of Hillstream Biopharma i.e., Hillstream Biopharma and Acrivon Therapeutics, go up and down completely randomly.
Pair Corralation between Hillstream Biopharma and Acrivon Therapeutics,
Given the investment horizon of 90 days Hillstream Biopharma is expected to generate 0.84 times more return on investment than Acrivon Therapeutics,. However, Hillstream Biopharma is 1.19 times less risky than Acrivon Therapeutics,. It trades about 0.08 of its potential returns per unit of risk. Acrivon Therapeutics, Common is currently generating about 0.01 per unit of risk. If you would invest 36.00 in Hillstream Biopharma on September 1, 2024 and sell it today you would earn a total of 3.00 from holding Hillstream Biopharma or generate 8.33% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 8.06% |
| Values | Daily Returns |
Hillstream Biopharma vs. Acrivon Therapeutics, Common
Performance |
| Timeline |
| Hillstream Biopharma |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Acrivon Therapeutics, |
Hillstream Biopharma and Acrivon Therapeutics, Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Hillstream Biopharma and Acrivon Therapeutics,
The main advantage of trading using opposite Hillstream Biopharma and Acrivon Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Hillstream Biopharma position performs unexpectedly, Acrivon Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Acrivon Therapeutics, will offset losses from the drop in Acrivon Therapeutics,'s long position.| Hillstream Biopharma vs. Virax Biolabs Group | Hillstream Biopharma vs. Revelation Biosciences | Hillstream Biopharma vs. Kiora Pharmaceuticals | Hillstream Biopharma vs. ZyVersa Therapeutics |
| Acrivon Therapeutics, vs. Aerovate Therapeutics | Acrivon Therapeutics, vs. Adagene | Acrivon Therapeutics, vs. Rezolute | Acrivon Therapeutics, vs. AN2 Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Other Complementary Tools
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |